Research Library

This study leverages validated patient-reported outcomes measures  to analyze the association between "financial toxicity" and quality of life and satisfaction among women undergoing ablative breast cancer surgery. Journal of the American College of Surgeons

To understand the variations and impact of national policies, the authors reviewed and analyzed IVF, hESC and human embryo research laws or national guidelines currently in place in the top R&D-investing nations. Regenerative Medicine, Aug. 17, 2020.

This study highlights areas where efforts could be made to address policy issues, institutional barriers and national biases to promote more productive collaboration in the global scientific community.

Gene editing in humans raises ethical and safety issues that require further discussion to identify a responsible way forward.

The connection between Texas H.B. 810, which allows clinics to provide investigational stem cell treatments to certain patients, and a deregulation movement to increase patient access to unproven stem cell treatments is described in this report.

Private cord blood banking is more widespread than public banking in Jordan, contributing to misinformation and unequal access to resources. The authors conducted surveys with women in Jordan to examine perspectives toward cord banking in the country in order to inform policymaking, ethics and education about the practice.

The dramatic deterioration in state finances during the Great Recession raised concerns regarding government’s ability to support community health and education. In this study published in the National Tax Journal, the authors find that state revenue declines lead to short and long terms cuts in children’s Medicaid benefits, and declines in elderly Medicaid enrollment, and that larger cuts (nominal and proportional) in education spending versus Medicaid occurred.

A growing number of stem cell clinics treat a variety of illnesses and injuries, yet few have conducted the necessary clinical research to ensure safety and efficacy. The authors highlight the importance of collaboration between scientists, regulators, patients and patient advocates in developing effective policies and practices for unproven stem cell-based intervention clinics.

The authors explore the different scientific values and priorities that should be considered in setting the policy agenda for effectively combating neglected tropical diseases (NTDs) and argue that researchers and physicians should participate in this process.

As his term progresses, President Trump will be faced with a large number of policy challenges, some of them requiring immediate science & technology expertise. In this Science Magazine article, the authors urge the president to consider the Office of Science & Technology Policy, the science advisor and the presidential S&T councils as vital resources that should be used early in the term to drive his policy agenda.